France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

"We are proud to introduce the Digital Certificate of Pharmaceutical Product, which will bring Pakistan's pharmaceutical industry in line with global best practices," said Aftab Haider, CEO of ...

Explore QuantumScape's Q1 2025 earnings call insights, featuring progress on solid-state battery tech, Cobra process milestones, and partnerships ...

During the preclinical stage, the focus of forecasting is not necessarily on the product itself ... largest and most respected events for bio & pharmaceutical manufacturing professionals.

The Trump administration is expected to announce tariffs on pharmaceuticals "in the next month or two," an official said. | The Trump administration is expected to announce tariffs on pharmaceuticals ...

Despite this growth, Africa still imports over 80% of its pharmaceutical products, compared to India’s 5%, due to limited manufacturing capacity. USAID cuts under the Trump administration slashed ...

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

As the prescriber and payer environment for launching new pharmaceutical products becomes more challenging, pharmaphorum catches up with Cegedim Strategic Data's Adam Harris to hear his views on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.